The hyperglycemic and antidiuretic activity of a phthalimidine analogue: 1-oxo-3-(4'-chlorophenyl)-3-hydroxyisoindoline (C3-176).
D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure / Q000187:drug effects; D002395:Catecholamines / Q000097:blood; D002752:Chlorthalidone / Q000494:pharmacology; D003981:Diazoxide / Q000494:pharmacology; D004231:Diuresis / Q000187:drug effects*; D004285:Dogs; D005215:Fasting; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005947:Glucose / Q000494:pharmacology; D006943:Hyperglycemia / Q000139:chemically induced*; D066298:In Vitro Techniques; D007211:Indoles / Q000494:pharmacology*; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D007328:Insulin / Q000096:biosynthesis / Q000097:blood / Q000494:pharmacology; D008297:Male; D010179:Pancreas / Q000187:drug effects; D011817:Rabbits; D051381:Rats
D001786:Blood Glucose; D002395:Catecholamines; D005230:Fatty Acids, Nonesterified; D007211:Indoles; D007328:Insulin; D005947:Glucose; D003981:Diazoxide; D002752:Chlorthalidone